Pharmacologic inhibition of MGL in primary human esophageal epithelial cells led to a more “EoE-prone” phenotype expression and increased ability of the epithelial cell secretome to activate and recruit eosinophils via CB2 receptors. This evidence concerns the gene MGLL and eosinophilic esophagitis.